GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HighTide Therapeutics Inc (HKSE:02511) » Definitions » PB Ratio

HighTide Therapeutics (HKSE:02511) PB Ratio : 3.63 (As of May. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is HighTide Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-21), HighTide Therapeutics's share price is HK$5.42. HighTide Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was HK$1.49. Hence, HighTide Therapeutics's PB Ratio of today is 3.63.

The historical rank and industry rank for HighTide Therapeutics's PB Ratio or its related term are showing as below:

HKSE:02511' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 4.91
Current: 3.64

During the past 3 years, HighTide Therapeutics's highest PB Ratio was 4.91. The lowest was 0.00. And the median was 0.00.

HKSE:02511's PB Ratio is ranked worse than
70.87% of 1325 companies
in the Biotechnology industry
Industry Median: 2.55 vs HKSE:02511: 3.64

Back to Basics: PB Ratio


HighTide Therapeutics PB Ratio Historical Data

The historical data trend for HighTide Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HighTide Therapeutics PB Ratio Chart

HighTide Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
PB Ratio
- - 8.68

HighTide Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio - - - - 8.68

Competitive Comparison of HighTide Therapeutics's PB Ratio

For the Biotechnology subindustry, HighTide Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HighTide Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HighTide Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where HighTide Therapeutics's PB Ratio falls into.



HighTide Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

HighTide Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=5.42/1.493
=3.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


HighTide Therapeutics  (HKSE:02511) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


HighTide Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of HighTide Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HighTide Therapeutics (HKSE:02511) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ganli Second Road, 18B-102, Zhonghaixin Innovation Industry City, Jihua Neighborhood, Longgang District, Guangdong, Shenzhen, CHN, 518112
HighTide Therapeutics Inc is a biopharmaceutical company specializing in the discovery, development and commercialization of multifunctional, multi-targeted therapies for the treatment of metabolic and digestive diseases. The company has developed a product pipeline of five product candidates in-house, covering nine indications in metabolic and digestive diseases among which, five are at clinical-stage. The Core Product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases.

HighTide Therapeutics (HKSE:02511) Headlines

No Headlines